Annual Working Capital
$828.20 K
-$1.80 M-68.54%
December 1, 2023
Summary
- As of February 7, 2025, TNFA annual working capital is $828.20 thousand, with the most recent change of -$1.80 million (-68.54%) on December 1, 2023.
- During the last 3 years, TNFA annual working capital has risen by +$3.03 million (+137.67%).
- TNFA annual working capital is now -92.88% below its all-time high of $11.63 million, reached on December 1, 2021.
Performance
TNFA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$5.04 M
-$3.54 M-41.24%
September 1, 2024
Summary
- As of February 7, 2025, TNFA quarterly working capital is $5.04 million, with the most recent change of -$3.54 million (-41.24%) on September 1, 2024.
- Over the past year, TNFA quarterly working capital has increased by +$4.21 million (+508.33%).
- TNFA quarterly working capital is now -84.22% below its all-time high of $31.92 million, reached on March 1, 2021.
Performance
TNFA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TNFA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.5% | +508.3% |
| 3 y3 years | +137.7% | -20.0% |
| 5 y5 years | +137.7% | -84.2% |
TNFA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -92.9% | at low | -65.6% | +433.0% |
| 5 y | 5-year | -92.9% | +137.7% | -84.2% | +329.1% |
| alltime | all time | -92.9% | +137.7% | -84.2% | +329.1% |
TNF Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.04 M(-41.2%) |
| Jun 2024 | - | $8.57 M(-666.8%) |
| Mar 2024 | - | -$1.51 M(-282.7%) |
| Dec 2023 | $828.20 K(-68.5%) | $828.20 K(-79.5%) |
| Sep 2023 | - | $4.04 M(-62.3%) |
| Jun 2023 | - | $10.71 M(-26.9%) |
| Mar 2023 | - | $14.66 M(+456.9%) |
| Dec 2022 | $2.63 M | $2.63 M(-58.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $6.30 M(+54.0%) |
| Jun 2022 | - | $4.09 M(-46.2%) |
| Mar 2022 | - | $7.61 M(-34.6%) |
| Dec 2021 | $11.63 M(-628.8%) | $11.63 M(-16.1%) |
| Sep 2021 | - | $13.86 M(-27.2%) |
| Jun 2021 | - | $19.03 M(-40.4%) |
| Mar 2021 | - | $31.92 M(-1552.0%) |
| Dec 2020 | -$2.20 M | -$2.20 M |
FAQ
- What is TNF Pharmaceuticals annual working capital?
- What is the all time high annual working capital for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals annual working capital year-on-year change?
- What is TNF Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals quarterly working capital year-on-year change?
What is TNF Pharmaceuticals annual working capital?
The current annual working capital of TNFA is $828.20 K
What is the all time high annual working capital for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high annual working capital is $11.63 M
What is TNF Pharmaceuticals annual working capital year-on-year change?
Over the past year, TNFA annual working capital has changed by -$1.80 M (-68.54%)
What is TNF Pharmaceuticals quarterly working capital?
The current quarterly working capital of TNFA is $5.04 M
What is the all time high quarterly working capital for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high quarterly working capital is $31.92 M
What is TNF Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, TNFA quarterly working capital has changed by +$4.21 M (+508.33%)